Companies: 10,795·Total market cap: $144.5T
LifeStance Health Group, Inc.

LifeStance Health Group, Inc.

LFSTNASDAQHealthcare● Active
$7.34
$-0.07(-0.93%)
Market Cap$2.8B
P/E Ratio
52W High$8.89
52W Low$3.74
Overview

LifeStance Health Group, Inc. (LFST) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

lfst · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Buy

11 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
9
Hold
2
Sell
0
Strong Sell
0
Total: 11 · Buy rate: 81.8%

12-Month Price Target

High

$11.00

Consensus

$9.58

+29.7% upside

Low

$8.00

Median: $9.5 · Last Close: $7.39

The LifeStance Health Group, Inc. (LFST) analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month LFST price target is $9.58, representing +29.7% upside from the current price of $7.39.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $10 (29.7%)

Consensus Target

$9.58

29.7% upside

High Target

$11

48.9%

Low Target

$8

8.3%

Current Price

$7.39

as of today

Based on analyst price targets, the LFST stock price prediction for the next 12 months ranges from $8 to $11. The consensus LFST price forecast of $9.58 implies 29.7% upside from the current price of $7.39.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$7.271.61%

1-day model range: $7.2–$7.33. Peak: $7.33 (-1.61%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$6-19.9%
2028$5-29.4%
2029$5-34.5%
2030$5-37.3%
2031-38.9%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%
7Buy
1Neutral
6Sell
RSI (14)39.6Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · LFST · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$7.54SELL
MA 10$7.63SELL
MA 20$7.68SELL
MA 50$7.22BUY
MA 100$7.09BUY
MA 200$6.52BUY
Current $LFST · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$7.51SELL
EMA 10$7.58SELL
EMA 20$7.58SELL
EMA 50$7.37BUY
EMA 100$7.09BUY
EMA 200$6.75BUY
Current $LFST · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Goldman Sachs2026-06-05
Downgrade ↓
BuyNeutral
JP Morgan2026-05-14
Maintains
NeutralNeutral
BTIG2026-05-08
Maintains
BuyBuy
Barclays2026-03-06
Maintains
OverweightOverweight
Canaccord Genuity2026-02-26
Maintains
BuyBuy
Keybanc2026-02-26
Maintains
OverweightOverweight
UBS2026-02-26
Maintains
BuyBuy
BTIG2026-02-02
Maintains
BuyBuy
BTIG2025-12-12
Maintains
BuyBuy
UBS2025-11-07
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on LifeStance Health Group, Inc. (LFST) stock. Of the recent 41 rating actions, 3 were upgrades and 4 were downgrades. 11 analysts currently cover LFST.

Analyst Recommendation Trends

Buy ratings202
Hold ratings01↑ +1
Sell ratings00

LFST analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1.2B

↓ 25.4% YoY

Revenue Next Year

$1.4B

↑ 14.6% YoY

EPS This Year

$-0.17

EPS Next Year

$-0.00

↓ 97.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast LFST EPS of $-0.17 for the current fiscal year, based on estimates from 2 analysts. The LFST revenue forecast is $1.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The LFST stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LFST price target is $9.58 (+29.7% upside), with an analyst consensus of Buy.

The LFST short-term stock prediction for tomorrow is $7.27 (-1.61%). The LFST stock price prediction for 2027 estimates an average of $6. The LFST stock prediction for 2030 projects a range of $4–$5.

LifeStance Health Group, Inc. trades on NASDAQ under the ticker LFST. The LFST stock outlook for 2027 is broadly positive, supported by a Buy consensus among 82% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

LFST forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month LFST price target is $9.58, with a high forecast of $11.00 and a low of $8.00. The median price target is shown in the chart above when available. This implies +29.7% potential upside from the current price of $7.39.

LFST price targetWhat is LFST price targetLFST analyst price targetLFST 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.